Ouji-Sageshima, N.; Hiyama, A.; Kumamoto, M.; Kitabatake, M.; Hara, A.; Furukawa, R.; Hontsu, S.; Kawaguchi, T.; Sawabata, N.; Muro, S.;
et al. Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients. Cells 2024, 13, 2050.
https://doi.org/10.3390/cells13242050
AMA Style
Ouji-Sageshima N, Hiyama A, Kumamoto M, Kitabatake M, Hara A, Furukawa R, Hontsu S, Kawaguchi T, Sawabata N, Muro S,
et al. Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients. Cells. 2024; 13(24):2050.
https://doi.org/10.3390/cells13242050
Chicago/Turabian Style
Ouji-Sageshima, Noriko, Aiko Hiyama, Makiko Kumamoto, Masahiro Kitabatake, Atsushi Hara, Ryutaro Furukawa, Shigeto Hontsu, Takeshi Kawaguchi, Noriyoshi Sawabata, Shigeo Muro,
and et al. 2024. "Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients" Cells 13, no. 24: 2050.
https://doi.org/10.3390/cells13242050
APA Style
Ouji-Sageshima, N., Hiyama, A., Kumamoto, M., Kitabatake, M., Hara, A., Furukawa, R., Hontsu, S., Kawaguchi, T., Sawabata, N., Muro, S., & Ito, T.
(2024). Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients. Cells, 13(24), 2050.
https://doi.org/10.3390/cells13242050
